Rxmp Therapeutics, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersMiami, FL
SAM.gov UEIG4WJF178TNG5
RxMP Therapeutics develops novel systemically-delivered hemostatic agents designed to arrest or prevent excessive bleeding resulting from trauma, surgery, bleeding disorders, or other causes. The company holds exclusive rights to technology for manufacturing hemostatic agents based on red cell-derived microparticles. The company serves healthcare applications where excessive bleeding prevention is needed.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Rxmp Therapeutics, INC. | Miami | FL | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.